SPONSOR
Regina Elena Cancer Institute
Total Trials
4
Recruiting
4
Phases
Phase 3
Conditions studied: Non-Small Cell Lung CancerProstate CarcinomaErectile FunctionGenito Urinary CancerSquamous Cell Carcinoma of the OropharynxCarcinomas of Unknown Primary SiteHigh-risk Human Papillomavirus InfectionLiquid BiopsyLymph Node MetastasisOccult Tumor of the Head and Neck Area
Regina Elena Cancer Institute is a clinical research sponsor with 4 registered studies on ClinicalTrials.gov, of which 4 are actively recruiting participants. Research covers conditions including Non-Small Cell Lung Cancer, Prostate Carcinoma, Erectile Function, Genito Urinary Cancer.
The trial portfolio spans Phase 3 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — Regina Elena Cancer Institute
How many clinical trials has Regina Elena Cancer Institute sponsored?
ClinicalMetric currently tracks 4 clinical trials sponsored by Regina Elena Cancer Institute, of which 4 are actively recruiting participants. These trials cover conditions including Non-Small Cell Lung Cancer, Prostate Carcinoma, Erectile Function. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does Regina Elena Cancer Institute research focus on?
Regina Elena Cancer Institute clinical trials span Non-Small Cell Lung Cancer, Prostate Carcinoma, Erectile Function, Genito Urinary Cancer, Squamous Cell Carcinoma of the Oropharynx, and additional conditions. The research pipeline includes Phase 3 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a Regina Elena Cancer Institute clinical trial?
To participate in a Regina Elena Cancer Institute trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all Regina Elena Cancer Institute trials with current recruitment status updated daily.
Clinical Trials by Regina Elena Cancer Institute
NCT07629375
Recruiting
Standardization of a Platform of Preclinical Models Derived From NSCLC Patients
Non-Small Cell Lung Cancer
NCT06717711 Phase 3
Recruiting
Low-Intensity Extracorporeal Shockwave Therapy on Penile Rehabilitation After Robot-assisted Surgical Treatment of Genitourinary Cancers
Prostate Carcinoma
NCT05918510
Recruiting
Observational Study of Viral BIOmarkers and microRNAs in Tumors Orofarynx and Occult Tumors Positive for Papilloma Virus
Squamous Cell Carcinoma of the Oropharynx
NCT05789667
Recruiting
Gender-based Impact on Safety and Efficacy of Lenvatinib in Patients With Differentiated Thyroid Cancer
Differentiated Thyroid Cancer
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: April 2026 · Data Methodology